1. Medtech Insight
  2. >>Business

Bono-Backed Investment Fund Props Reflexion Medical In Final Funding Round

RefleXion Medical says it has received Series C funding from The Rise Fund, an investment fund linked to philanthropists such as U2 singer Bono that aims to support companies that not only give returns on investment, but are socially and environmentally conscious as well.

RefleXion Medical, a California-based start-up that is developing what it says is the first and only biology-guided radiotherapy system (BgRT) to individually target and treat cancers says it has raised more than $100m in Series C round funding. The company said the effort was led by The Rise Fund, an investment fund managed by TPG Growth, which is co-led by a number of philanthropic investors including U2 singer Bono and billionaire Jeff Skoll.

RefleXion notes other investment partners included T. Rowe Price Associates, GT Healthcare Capital Partners, Sofinnova Partners, KCK Group and Venrock, and corporate investors such as Pfizer Venture Investments and Johnson...

More from Business

More from Medtech Insight

TRiCares Tricuspid Valve Replacement System Reduces Regurgitation In First-In-Human Study

 
• By Natasha Barrow

TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.

Swiss Medtechs Advised To Work On US Tariff Mitigation Strategies

 
• By Ashley Yeo

The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.

Guardant Health Launches Germline Hereditary Cancer Test

 
• By Natasha Barrow

Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.